However, systemic inflammation is closely involved in the pathogenesis of MetS, and thus, elevated hs-CRP may also reflect inflammation, which impairs insulin signaling in the liver, muscle, and adipose tissues, and influence insulin resistance, lipid and glucose metabolism (Kawamoto et al. 2013). This evidence concerns the gene INS and metabolic syndrome.